]>
IRCT20231105059968N1 IRCT 2024-01-22 Esfahan University of Medical Sciences The therapeutic effect of Tecar on patients with plantar fasciitis Investigating the effect of Tacar treatment on improving symptoms and performance of patients with plantar fasciitis and comparing it with drug treatment 2025-02-19 anticipated 60 Complete https://irct.ir/trial/74424 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients who will enter the study phase will be randomly assigned to one of the two intervention groups. The randomization method is that 25 random numbers from 1 to 50 are created by random number generation software, which are assigned to the first intervention group, and then the remaining 25 numbers are assigned to the second group, Blinding description: data analysts are unaware of which group each patient was placed in. N/A Plantar fasciitis. Intervention 1: Intervention group: Tecarotherapy (8 sessions: 2 days a week) and exercise (including stretching of calf muscles, plantar fascia, passive dorsiflexion of fingers, strengthening of intrinsic foot muscles and rolling soles, 9 times a day, including 3 times in the morning, 3 times in the afternoon, 3 times in the evening, 30 seconds each time) and (Soft medial longitudinal arch support or Silicon Heel Pad) is prescribed along with medicine (Celecoxib 200 mg, once a day for 15 days). Intervention 2: Control group: Exercise (including stretching of calf muscles, plantar fascia, passive dorsiflexion of fingers, strengthening of intrinsic foot muscles, rolling soles, 9 times a day, including 3 times in the morning, 3 times in the afternoon, 3 times at night, 30 seconds each time) along with medicine (Celecoxib 200 mg, once a day) for 15 days) and (Soft medial longitudinal arch support or Silicon Heel Pad) are prescribed. After the completion of the treatments, the pain level of the patients by VAS), the severity of the symptoms and the performance of the patients by the RM questionnaire will be measured again immediately after the end of the treatment and 2 months after the end of the treatment and with the other group and also at the beginning of the treatment under Comparison will be made. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no further information
public Razieh Maghroori
Hezar jarib Street, Isfahan University of Medical Science and health services
isfahan Iran (Islamic Republic of) 8174673461 +98 31 3668 0048 ramaghroori@yahoo.com Esfahan University of Medical Sciences scientific Fatemeh Izadi Najafabadi
Isfahan university of medical science, Hezarjarib Ave
isfahan Iran (Islamic Republic of) 8174673461 +98 31 3668 0048 Fatemeh.izadi68@yahoo.com Esfahan University of Medical Sciences Iran (Islamic Republic of) Diagnosis of plantar fasciitis (worsening of the pain in the inner part of the heel in the morning after waking up and also after a lot of activity during the day and the presence of local tenderness in the lower inner part of the calcaneus) by a physical medicine and rehabilitation specialist with a physical examination Heel pain for at least 4 weeks Age between 18 and 68 years Presence of VAS greater than 3 Informed written consent to participate in the study 18 years 68 years Both History of inflammatory joint disease Achilles tendon or nerve damage History of heel surgery or injection in the last 6 months History of injury to the affected heel The presence of diseases mimicking the symptoms of plantar fasciitis Contraindications of the Tecar device (pregnancy, pacemaker, insulin pump, growth plate, cancer, open wound and skin lesions, skin sensitivity, insensitivity to heat) Patients with intense physical activity or sports who are unable to reduce their activity level M72.2 Plantar fascial fibromatosis Treatment - Other Treatment - Other Intervention group: Tecarotherapy (8 sessions: 2 days a week) and exercise (including stretching of calf muscles, plantar fascia, passive dorsiflexion of fingers, strengthening of intrinsic foot muscles and rolling soles, 9 times a day, including 3 times in the morning, 3 times in the afternoon, 3 times in the evening, 30 seconds each time) and (Soft medial longitudinal arch support or Silicon Heel Pad) is prescribed along with medicine (Celecoxib 200 mg, once a day for 15 days). Control group: Exercise (including stretching of calf muscles, plantar fascia, passive dorsiflexion of fingers, strengthening of intrinsic foot muscles, rolling soles, 9 times a day, including 3 times in the morning, 3 times in the afternoon, 3 times at night, 30 seconds each time) along with medicine (Celecoxib 200 mg, once a day) for 15 days) and (Soft medial longitudinal arch support or Silicon Heel Pad) are prescribed. After the completion of the treatments, the pain level of the patients by VAS), the severity of the symptoms and the performance of the patients by the RM questionnaire will be measured again immediately after the end of the treatment and 2 months after the end of the treatment and with the other group and also at the beginning of the treatment under Comparison will be made. Pain. Timepoint: The severity of symptoms and performance of patients before the treatment will be measured again immediately after the end of the treatment and 2 months after the end of the treatment. Method of measurement: Pain level of patients by Visual Analogue Scale questionnaire - intensity of symptoms and performance of patients by RM(The modified Roles and Maudsley) questionnaire. Esfahan University of Medical Sciences Approved 2023-10-19 Ethics committee of Isfahan University of Medical Science Hezarjerib ave, Isfahan University of Medical Science isfahan Isfehan Iran (Islamic Republic of)